Compounds > 1,9-dideoxyforskolin
Page last updated: 2024-09-02

1,9-dideoxyforskolin and EHS Tumor

1,9-dideoxyforskolin has been researched along with EHS Tumor in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wadler, S; Yang, CP1
Wadler, S; Wiernik, PH1

Other Studies

2 other study(ies) available for 1,9-dideoxyforskolin and EHS Tumor

ArticleYear
Reversal of doxorubicin resistance by hydrophobic, but not hydrophilic, forskolins.
    Molecular pharmacology, 1991, Volume: 40, Issue:6

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chemical Phenomena; Chemistry, Physical; Colforsin; Cyclic AMP; Doxorubicin; Drug Resistance; Membrane Glycoproteins; Mice; Sarcoma, Experimental; Signal Transduction; Tumor Cells, Cultured

1991
Partial reversal of doxorubicin resistance by forskolin and 1,9-dideoxyforskolin in murine sarcoma S180 variants.
    Cancer research, 1988, Feb-01, Volume: 48, Issue:3

    Topics: Animals; Biological Transport; Cell Survival; Colforsin; Colony-Forming Units Assay; Cyclic AMP; Dose-Response Relationship, Drug; Drug Resistance; Sarcoma, Experimental; Tumor Cells, Cultured

1988